Pharmacological activation of aldehyde dehydrogenase 2 inhibits ferroptosis via SLC7A11/GPX4 axis to reduce kidney stone formation
Jingdong Zhang(Liaoning Cancer Hospital & Institute), Chunyu Liu(Chinese PLA General Hospital), Haotian Ren(Second Hospital of Tianjin Medical University), Linguo Xie(Second Hospital of Tianjin Medical University), Rui Wang(Second Hospital of Tianjin Medical University), Haijie Xie(Second Hospital of Tianjin Medical University), Zhiqun Shang(Second Hospital of Tianjin Medical University), Di Luo(Shandong University of Traditional Chinese Medicine), Yang Yu(Second Hospital of Tianjin Medical University)
Cited by 13
Related Papers
Gemstone nanoflower-shaped ZnIn2S4/CuS heterojunction with ultralong lifetime of photoinduced carriers for photocatalytic hydrogen evolution
|Applied Catalysis B: Environmental|2024|62
Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
|Frontiers in Pharmacology|2024|29
Characteristics of the gut microbiota and serum metabolites in postmenopausal women with reduced bone mineral density
|Frontiers in Cellular and Infection Microbiology|2024|27
Hydrogen (H2) Alleviates Osteoarthritis by Inhibiting Apoptosis and Inflammation via the JNK Signaling Pathway
|Journal of Inflammation Research|2021|26
Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer
|Annals of Translational Medicine|2019|22